ID CXCL5_HUMAN Reviewed; 114 AA. AC P42830; Q96QE1; DT 01-NOV-1995, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1995, sequence version 1. DT 27-MAR-2024, entry version 189. DE RecName: Full=C-X-C motif chemokine 5; DE AltName: Full=ENA-78(1-78); DE AltName: Full=Epithelial-derived neutrophil-activating protein 78; DE AltName: Full=Neutrophil-activating peptide ENA-78; DE AltName: Full=Small-inducible cytokine B5; DE Contains: DE RecName: Full=ENA-78(8-78); DE Contains: DE RecName: Full=ENA-78(9-78); DE Flags: Precursor; GN Name=CXCL5; Synonyms=ENA78, SCYB5; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=7828901; DOI=10.1016/0378-1119(94)90682-3; RA Power C.A., Furness R.B., Brawand C., Wells T.N.C.; RT "Cloning of a full-length cDNA encoding the neutrophil-activating peptide RT ENA-78 from human platelets."; RL Gene 151:333-334(1994). RN [2] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=7929219; DOI=10.1016/s0021-9258(18)47243-2; RA Chang M.S., McNinch J., Basu R., Simonet S.; RT "Cloning and characterization of the human neutrophil-activating peptide RT (ENA-78) gene."; RL J. Biol. Chem. 269:25277-25282(1994). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=7999089; DOI=10.1006/bbrc.1994.2709; RA Corbett M.S., Schmitt I., Riess O., Walz A.; RT "Characterization of the gene for human neutrophil-activating peptide 78 RT (ENA-78)."; RL Biochem. Biophys. Res. Commun. 205:612-617(1994). RN [4] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=11468158; DOI=10.1182/blood.v98.3.610; RA Zhang C., Thornton M.A., Kowalska M.A., Sachis B.S., Feldman M., Poncz M., RA McKenzie S.E., Reilly M.P.; RT "Localization of distal regulatory domains in the megakaryocyte-specific RT platelet basic protein/platelet factor 4 gene locus."; RL Blood 98:610-617(2001). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Kidney; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [6] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 38-80. RA Amoli M.M., Thomson W., Hajeer A.H., Gonzalez-Gay M.A., Ollier W.E.R.; RT "Novel polymorphism in ENA-78 gene."; RL Submitted (JUN-2001) to the EMBL/GenBank/DDBJ databases. RN [7] RP NUCLEOTIDE SEQUENCE [MRNA] OF 43-114. RC TISSUE=Epithelium; RX PubMed=1744577; DOI=10.1084/jem.174.6.1355; RA Walz A., Burgener R., Car B., Baggiolini M., Kunkel S.L., Strieter R.M.; RT "Structure and neutrophil-activating properties of a novel inflammatory RT peptide (ENA-78) with homology to interleukin 8."; RL J. Exp. Med. 174:1355-1362(1991). RN [8] RP PROTEIN SEQUENCE OF 37-51, IDENTIFICATION OF ENA-78(8-78) AND ENA-78(9-78), RP PROTEOLYTIC PROCESSING OF N-TERMINUS, AND FUNCTION. RC TISSUE=Peripheral blood monocyte; RX PubMed=10095777; DOI=10.1046/j.1432-1327.1999.00166.x; RA Wuyts A., Govaerts C., Struyf S., Lenaerts J.-P., Put W., Conings R., RA Proost P., Van Damme J.; RT "Isolation of the CXC chemokines ENA-78, GRO alpha and GRO gamma from tumor RT cells and leukocytes reveals NH2-terminal heterogeneity. Functional RT comparison of different natural isoforms."; RL Eur. J. Biochem. 260:421-429(1999). RN [9] RP PROTEIN SEQUENCE OF 37-45. RC TISSUE=Platelet; RX PubMed=12665801; DOI=10.1038/nbt810; RA Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R., RA Vandekerckhove J.; RT "Exploring proteomes and analyzing protein processing by mass spectrometric RT identification of sorted N-terminal peptides."; RL Nat. Biotechnol. 21:566-569(2003). RN [10] RP REVIEW. RX PubMed=14711052; DOI=10.1016/s0065-2776(03)81001-5; RA Struyf S., Proost P., Van Damme J.; RT "Regulation of the immune response by the interaction of chemokines and RT proteases."; RL Adv. Immunol. 81:1-44(2003). RN [11] {ECO:0007744|PDB:2MGS} RP STRUCTURE BY NMR OF 37-114, DISULFIDE BONDS, AND SUBUNIT. RX PubMed=24695525; DOI=10.1371/journal.pone.0093228; RA Sepuru K.M., Poluri K.M., Rajarathnam K.; RT "Solution structure of CXCL5--a novel chemokine and adipokine implicated in RT inflammation and obesity."; RL PLoS ONE 9:E93228-E93228(2014). CC -!- FUNCTION: Involved in neutrophil activation. In vitro, ENA-78(8-78) and CC ENA-78(9-78) show a threefold higher chemotactic activity for CC neutrophil granulocytes. {ECO:0000269|PubMed:10095777}. CC -!- SUBUNIT: Monomer (PubMed:24695525). Homodimer (PubMed:24695525). CC {ECO:0000269|PubMed:24695525}. CC -!- INTERACTION: CC P42830; Q08043: ACTN3; NbExp=3; IntAct=EBI-12175919, EBI-2880652; CC P42830; P05187: ALPP; NbExp=3; IntAct=EBI-12175919, EBI-1211484; CC P42830; O95967: EFEMP2; NbExp=3; IntAct=EBI-12175919, EBI-743414; CC P42830; P23142-4: FBLN1; NbExp=3; IntAct=EBI-12175919, EBI-11956479; CC P42830; P28799: GRN; NbExp=3; IntAct=EBI-12175919, EBI-747754; CC P42830; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-12175919, EBI-16439278; CC P42830; B2RUY7: VWC2L; NbExp=3; IntAct=EBI-12175919, EBI-11747707; CC -!- SUBCELLULAR LOCATION: Secreted. CC -!- PTM: N-terminal processed forms ENA-78(8-78) and ENA-78(9-78) are CC produced by proteolytic cleavage after secretion from peripheral blood CC monocytes. {ECO:0000269|PubMed:10095777}. CC -!- SIMILARITY: Belongs to the intercrine alpha (chemokine CxC) family. CC {ECO:0000305}. CC -!- WEB RESOURCE: Name=Wikipedia; Note=CXCL5 entry; CC URL="https://en.wikipedia.org/wiki/CXCL5"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; X78686; CAA55355.1; -; mRNA. DR EMBL; U12709; AAA62475.1; -; Genomic_DNA. DR EMBL; L37036; AAA86426.1; -; Genomic_DNA. DR EMBL; AF349466; AAK29641.1; -; Genomic_DNA. DR EMBL; BC008376; AAH08376.1; -; mRNA. DR EMBL; AJ315732; CAC42884.1; -; Genomic_DNA. DR CCDS; CCDS34006.1; -. DR PIR; JC2433; A55010. DR RefSeq; NP_002985.1; NM_002994.4. DR PDB; 2MGS; NMR; -; A/B=37-114. DR PDBsum; 2MGS; -. DR AlphaFoldDB; P42830; -. DR BMRB; P42830; -. DR SMR; P42830; -. DR BioGRID; 112276; 50. DR DIP; DIP-5911N; -. DR IntAct; P42830; 16. DR STRING; 9606.ENSP00000296027; -. DR iPTMnet; P42830; -. DR PhosphoSitePlus; P42830; -. DR BioMuta; CXCL5; -. DR DMDM; 1169525; -. DR EPD; P42830; -. DR MassIVE; P42830; -. DR PaxDb; 9606-ENSP00000296027; -. DR PeptideAtlas; P42830; -. DR ProteomicsDB; 55559; -. DR ABCD; P42830; 2 sequenced antibodies. DR Antibodypedia; 13336; 595 antibodies from 36 providers. DR DNASU; 6374; -. DR Ensembl; ENST00000296027.5; ENSP00000296027.4; ENSG00000163735.7. DR GeneID; 6374; -. DR KEGG; hsa:6374; -. DR MANE-Select; ENST00000296027.5; ENSP00000296027.4; NM_002994.5; NP_002985.1. DR AGR; HGNC:10642; -. DR CTD; 6374; -. DR DisGeNET; 6374; -. DR GeneCards; CXCL5; -. DR HGNC; HGNC:10642; CXCL5. DR HPA; ENSG00000163735; Group enriched (lymphoid tissue, salivary gland). DR MIM; 600324; gene. DR neXtProt; NX_P42830; -. DR OpenTargets; ENSG00000163735; -. DR PharmGKB; PA35573; -. DR VEuPathDB; HostDB:ENSG00000163735; -. DR eggNOG; ENOG502S7MM; Eukaryota. DR GeneTree; ENSGT00940000163567; -. DR HOGENOM; CLU_143902_1_0_1; -. DR InParanoid; P42830; -. DR OMA; HPKMISN; -. DR OrthoDB; 4170999at2759; -. DR PhylomeDB; P42830; -. DR TreeFam; TF333433; -. DR PathwayCommons; P42830; -. DR Reactome; R-HSA-380108; Chemokine receptors bind chemokines. DR Reactome; R-HSA-418594; G alpha (i) signalling events. DR SignaLink; P42830; -. DR BioGRID-ORCS; 6374; 15 hits in 1117 CRISPR screens. DR GeneWiki; CXCL5; -. DR GenomeRNAi; 6374; -. DR Pharos; P42830; Tbio. DR PRO; PR:P42830; -. DR Proteomes; UP000005640; Chromosome 4. DR RNAct; P42830; Protein. DR Bgee; ENSG00000163735; Expressed in monocyte and 123 other cell types or tissues. DR ExpressionAtlas; P42830; baseline and differential. DR GO; GO:0005576; C:extracellular region; TAS:Reactome. DR GO; GO:0005615; C:extracellular space; IBA:GO_Central. DR GO; GO:0008009; F:chemokine activity; IBA:GO_Central. DR GO; GO:0045236; F:CXCR chemokine receptor binding; IBA:GO_Central. DR GO; GO:0042802; F:identical protein binding; IDA:UniProtKB. DR GO; GO:0061844; P:antimicrobial humoral immune response mediated by antimicrobial peptide; IBA:GO_Central. DR GO; GO:0007267; P:cell-cell signaling; TAS:ProtInc. DR GO; GO:0071222; P:cellular response to lipopolysaccharide; IBA:GO_Central. DR GO; GO:0070098; P:chemokine-mediated signaling pathway; IBA:GO_Central. DR GO; GO:0006935; P:chemotaxis; TAS:ProtInc. DR GO; GO:0006954; P:inflammatory response; IBA:GO_Central. DR GO; GO:0030593; P:neutrophil chemotaxis; IBA:GO_Central. DR GO; GO:0008284; P:positive regulation of cell population proliferation; TAS:ProtInc. DR GO; GO:0007165; P:signal transduction; TAS:ProtInc. DR CDD; cd00273; Chemokine_CXC; 1. DR Gene3D; 2.40.50.40; -; 1. DR InterPro; IPR039809; Chemokine_b/g/d. DR InterPro; IPR001089; Chemokine_CXC. DR InterPro; IPR018048; Chemokine_CXC_CS. DR InterPro; IPR001811; Chemokine_IL8-like_dom. DR InterPro; IPR033899; CXC_Chemokine_domain. DR InterPro; IPR036048; Interleukin_8-like_sf. DR PANTHER; PTHR12015:SF190; C-X-C MOTIF CHEMOKINE 5; 1. DR PANTHER; PTHR12015; SMALL INDUCIBLE CYTOKINE A; 1. DR Pfam; PF00048; IL8; 1. DR PRINTS; PR00436; INTERLEUKIN8. DR PRINTS; PR00437; SMALLCYTKCXC. DR SMART; SM00199; SCY; 1. DR SUPFAM; SSF54117; Interleukin 8-like chemokines; 1. DR PROSITE; PS00471; SMALL_CYTOKINES_CXC; 1. DR Genevisible; P42830; HS. PE 1: Evidence at protein level; KW 3D-structure; Cytokine; Direct protein sequencing; Disulfide bond; KW Reference proteome; Secreted; Signal. FT SIGNAL 1..36 FT /evidence="ECO:0000269|PubMed:10095777, FT ECO:0000269|PubMed:12665801" FT CHAIN 37..114 FT /note="C-X-C motif chemokine 5" FT /id="PRO_0000005075" FT CHAIN 44..114 FT /note="ENA-78(8-78)" FT /id="PRO_0000005076" FT CHAIN 45..114 FT /note="ENA-78(9-78)" FT /id="PRO_0000005077" FT SITE 44..45 FT /note="Cleavage; by cathepsin G" FT DISULFID 49..75 FT /evidence="ECO:0000269|PubMed:24695525, FT ECO:0007744|PDB:2MGS" FT DISULFID 51..91 FT /evidence="ECO:0000269|PubMed:24695525, FT ECO:0007744|PDB:2MGS" FT HELIX 60..62 FT /evidence="ECO:0007829|PDB:2MGS" FT STRAND 63..69 FT /evidence="ECO:0007829|PDB:2MGS" FT STRAND 79..87 FT /evidence="ECO:0007829|PDB:2MGS" FT STRAND 89..92 FT /evidence="ECO:0007829|PDB:2MGS" FT HELIX 97..108 FT /evidence="ECO:0007829|PDB:2MGS" FT TURN 109..112 FT /evidence="ECO:0007829|PDB:2MGS" SQ SEQUENCE 114 AA; 11972 MW; 56B21EE86AE952D3 CRC64; MSLLSSRAAR VPGPSSSLCA LLVLLLLLTQ PGPIASAGPA AAVLRELRCV CLQTTQGVHP KMISNLQVFA IGPQCSKVEV VASLKNGKEI CLDPEAPFLK KVIQKILDGG NKEN //